- Market Capitalization, $K 1,392,922
- Shares Outstanding, K 56,348
- Annual Sales, $ 3,150 K
- Annual Income, $ -69,610 K
- 60-Month Beta 1.98
- Price/Sales 443.42
- Price/Cash Flow N/A
- Price/Book 4.92
|Period||Period Low||Period High||Performance|
| || |
-1.28 (-4.85%)since 10/28/22
| || |
+3.07 (+13.94%)since 08/29/22
| || |
+15.85 (+171.54%)since 11/26/21
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of 21.78% and 20.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...
Solid Biosciences Inc. (SLDB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rhythm Pharmaceuticals, Inc. (RYTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
September S&P 500 futures (ESU22) are moderately up +0.03% this morning after three major US benchmark indices bounced back during the regular session as an on-target inflation report mainly stopped the...
Here's why our roundtable is bullish on Shockwave Medical, Axsome Therapeutics, and Rhythm Pharmaceuticals.
Annovis Bio (ANVS) doses first patient in the phase III study evaluating buntanetap in early Parkinson's Disease. Stock surges.
Akero Therapeutics (AKRO) announces positive data from third cohort of its mid-stage study evaluating efruxifermin (EFX) in NASH. Stock up.
These three healthcare stocks have defied the 2022 bear market.
bluebird bio (BLUE) has surged in the past three months owing to its pipeline development. The company's lead candidate recently received FDA approval as a potential treatment for beta-thalassemia.
Aeglea BioTherapeutics (AGLE) seeks a nod for its lead candidate, pegzilarginase, for treating ARG1-D in the European Union. Stock surges post announcement.
|3rd Resistance Point||26.74|
|2nd Resistance Point||26.08|
|1st Resistance Point||25.58|
|1st Support Level||24.42|
|2nd Support Level||23.76|
|3rd Support Level||23.26|